Prevalence of microalbuminuria and risk factor analysis in type 2 diabetes patients in Albania: The need for accurate and early diagnosis of diabetic nephropathy

Hippokratia

Volumn 17, Issue 4, 2013, Pages 337-341

  Pasko, Nevi ^a   Toti, F ^a   Strakosha, A ^a   Thengjilli, E ^b   Shehu, A ^c   Dedej, T ^a   Ylli, A ^a   Thereska, N ^a  

^a UNIVERSITY HOSPITAL CENTER MOTHER TERESA   (Albania)

^b Regional Hospital   (Albania)

^c Laboratory 'Intermedica'   (Albania)

Author keywords

Albania; Epidemiology; Microalbuminuria; Type 2 diabetes

Indexed keywords

CREATININE; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; AGED; ALBANIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 84892402775     PISSN: 11084189     EISSN: 17908019     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. thedition. Brussels, 2011.
2. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997; 14: S1-S85.
3. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001; 414: 782-787.
4. Ritz E, Rychlík I, Locatelli F, Halimi S. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis. 1999; 34: 795-808.
5. Ritz E, Orth SR Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med. 1999; 341: 1127-1133.
6. Parving HH. Diabetic nephropathy: prevention and treatment. Kidney Int. 2001; 60: 2041-2055.
7. Shapo L, McKee M, Coker R, Ylli A. Type 2 diabetes in Tirana City, Albania: a rapid increase in a country in transition. Diabet Med. 2004; 21: 77-83.
8. International Diabetes Federation. IDF Diabetes Atlas [homepage on the Internet]. Available from: http://www.idf.org/diabetesatlas.
9. Doupis J, Tentolouris N, Mastrokostopoulos A, Kokkinos A, Doupis C, Zdrava A, et al. Prevalence of type 2 diabetes in the southwest Albanian adult population. Rural Remote Health. 2007; 7: 744.
10. Hostetter TH. Prevention of the development and progression of renal disease. J Am Soc Nephrol. 2003; 14: S144-S147.
11. de Jong PE, Hillege HL, Pinto-Sietsma SJ, de Zeeuw D. Screening for microalbuminuria in the general population: a tool to detect subjects at increased risk for progressive renal failure in an early phase? Nephrol Dial Transplant. 2003; 18: 10-13.
12. Heerspink HJ, Holtkamp FA, de Zeeuw D, Ravid M. Monitoring kidney function and albuminuria in patients with diabetes. Diabetes Care. 2011; 34 Suppl 2: S325-S329.
13. de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int. 2004; 65: 2309-2320.
14. Rowe DJ, Dawnay A, Watts GF. Microalbuminuria in diabetic subjects: review and recommendations for the measurement of albumin in urine. Ann Clin Biochem. 1990; 27: 297-312.
15. Croal BL, Mutch WJ, Clark BM, Dickie A, Church J, Noble D, et al. The clinical application of a urine albumin: creatinine ratio point-of-care device. Clin Chim Acta. 2001; 307: 15-21.
16. Marshall SM. Screening for microalbuminuria: which measurement? Diabet Med. 1991; 8: 706-711.
17. Rowe DJ, Dawnay A, Watts GF. Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in urine. Ann Clin Biochem. 1990; 27: 297-312.
18. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011; 305: 2532-2539.
19. Verhave JC, Gansevoort RT, Hillege HL, Bakker SJ, De Zeeuw D, de Jong PE; PREVEND Study Group. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int Suppl. 2004; 92: S18-S21.
20. Atkins RC, Briganti EM, Lewis JB, Hunsicker LG, Braden G, Champion de Crespigny PJ, et al. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis. 2005; 45: 281-287.
21. Bruno G, Cavallo-Perin P, Bargero G, Borra M, Calvi V, D'Errico N, et al. Prevalence and risk factors for micro-and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care. 1996; 19: 43-47.
22. Gall MA, Rossing P, Skøtt P, Damsbo P, Vaag A, Bech K, et al. Prevalence of micro-and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1991; 34: 655-661.
23. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG; DEMAND investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 2006; 69: 2057-2063.
24. Toti F, Bejtja G, Hoti K, Shota E, Agaçi F. Poor control and management of cardiovascular risk factors among Albanian diabetic adult patients. Prim Care Diabetes. 2007; 1: 81-86.
25. Mather HM, Chaturvedi N, Kehely AM. Comparison of prevalence and risk factors for microalbuminuria in south Asians and Europeans with type 2 diabetes mellitus. Diabetes Med. 1998; 15: 672-677.
26. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR; UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes. 2006; 55: 1832-1839.
27. Rosenson RS. Fenofibrate: treatment of hyperlipidemia and beyond. Expert Rev Cardiovasc Ther. 2008; 6: 1319-1330.
28. Nilsson PM, Gudbjörnsdottir S, Eliasson B, Cederholm J; Steering Committee of the Swedish National Diabetes Register. Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes--data from the National Diabetes Register in Sweden. Diabetes Metab. 2004; 30: 261-268.
29. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993; 329: 977-986.
30. Thomas MC, Macisaac RJ, Jerums G, Weekes A, Moran J, Shaw JE, et al. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment co-existing with NIDDM [NEFRON] 11). Diabetes Care. 2009; 32: 1497-1502.
31. Caramori ML, Fioretto P, Mauer M. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes. 2000; 49: 1399-1408.